CA2392576A1 - Inhibiteurs du facteur xa a base d'acides .beta.-amines, aspartiques et diaminopropioniques - Google Patents
Inhibiteurs du facteur xa a base d'acides .beta.-amines, aspartiques et diaminopropioniques Download PDFInfo
- Publication number
- CA2392576A1 CA2392576A1 CA002392576A CA2392576A CA2392576A1 CA 2392576 A1 CA2392576 A1 CA 2392576A1 CA 002392576 A CA002392576 A CA 002392576A CA 2392576 A CA2392576 A CA 2392576A CA 2392576 A1 CA2392576 A1 CA 2392576A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- alkyl
- member selected
- independently
- cooh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La présente invention concerne des composés à base d'acides .beta.-aminés, aspartiques et diaminopropioniques représentés par la formule générale A-Q-D-E-G-J-X, certains de leurs sels et des compositions s'y rapportant, tous actifs contre le facteur Xa mammalien. Les éléments A, Q, D, E, G, J et X de cette formule ont la signification qui en est donnée dans la description. Ces composés conviennent particulièrement pour la prévention ou le traitement de troubles de la coagulation, in vitro ou in vivo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16724099P | 1999-11-24 | 1999-11-24 | |
US60/167,240 | 1999-11-24 | ||
PCT/US2000/031520 WO2001038309A1 (fr) | 1999-11-24 | 2000-11-17 | INHIBITEURS DU FACTEUR Xa A BASE D'ACIDES β-AMINES, ASPARTIQUES ET DIAMINOPROPIONIQUES |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2392576A1 true CA2392576A1 (fr) | 2001-05-31 |
Family
ID=22606529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002392576A Abandoned CA2392576A1 (fr) | 1999-11-24 | 2000-11-17 | Inhibiteurs du facteur xa a base d'acides .beta.-amines, aspartiques et diaminopropioniques |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1235807A1 (fr) |
JP (1) | JP2003514897A (fr) |
AU (1) | AU1770001A (fr) |
CA (1) | CA2392576A1 (fr) |
WO (1) | WO2001038309A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
WO2004014844A2 (fr) | 2002-08-09 | 2004-02-19 | Transtech Pharma, Inc. | Composes aryle et heteroaryle et procedes de modulation de la coagulation |
US7208601B2 (en) | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
JP2007501844A (ja) | 2003-08-08 | 2007-02-01 | トランス テック ファーマ,インコーポレイテッド | アリール及びヘテロアリール化合物、組成物並びに使用方法 |
US7501538B2 (en) | 2003-08-08 | 2009-03-10 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
EP1571154A1 (fr) * | 2004-03-03 | 2005-09-07 | Aventis Pharma Deutschland GmbH | Dérivés du beta-alanine comme inhibiteurs du facteur Xa |
JP2005287503A (ja) * | 2004-04-01 | 2005-10-20 | Aventis Pharma Deutschland Gmbh | TAFI−Ile347多型を決定することによって血栓形成性障害に関する危険性を同定する方法 |
UY30892A1 (es) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | Inhibidores de la actividad akt |
TWI444379B (zh) | 2007-06-29 | 2014-07-11 | Sunesis Pharmaceuticals Inc | 有用於作為Raf激酶抑制劑之化合物 |
EP2167497A2 (fr) | 2007-06-29 | 2010-03-31 | Sunesis Pharmaceuticals, Inc. | Composés hétérocycliques utiles en tant qu'inhibiteurs de la kinase raf |
AU2009217075B2 (en) | 2008-02-21 | 2013-05-16 | Sanofi-Aventis | Chlorothiophene-amides as inhibitors of coagulation factors Xa and thrombin |
WO2009103439A1 (fr) * | 2008-02-21 | 2009-08-27 | Sanofi-Aventis | Chlorothiophène-isoxazoles utilisés comme inhibiteurs des facteurs de coagulation xa et de la thrombine |
AU2021359129A1 (en) * | 2020-10-16 | 2023-06-01 | Proxygen Gmbh | Heterocyclic cullin ring ubiquitin ligase compounds and uses thereof |
CN116410143A (zh) * | 2021-12-29 | 2023-07-11 | 杭州奥默医药股份有限公司 | 一种多取代脲嘧啶衍生物及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2150550A1 (fr) * | 1992-12-01 | 1994-06-09 | Melissa S. Egbertson | Antagonistes du recepteur du fibrinogene |
US5741796A (en) * | 1994-05-27 | 1998-04-21 | Merck & Co., Inc. | Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption |
WO1996039930A1 (fr) * | 1995-06-07 | 1996-12-19 | Minnesota Mining And Manufacturing Company | Electrode a usage biomedical a plaque de renforcement avec teton connecteur solidaire |
US6262069B1 (en) * | 1997-08-29 | 2001-07-17 | Protherics Molecular Design Limited | 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
RU2226529C2 (ru) * | 1997-12-19 | 2004-04-10 | Шеринг Акциенгезельшафт | Производные ортоантраниламида в качестве антикоагулянтов, фармацевтическая композиция и способ лечения |
CA2374793A1 (fr) * | 1999-05-24 | 2000-11-30 | Penglie Zhang | Inhibiteurs du facteur xa |
AU5283900A (en) * | 1999-05-24 | 2000-12-12 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
-
2000
- 2000-11-17 EP EP00980439A patent/EP1235807A1/fr not_active Withdrawn
- 2000-11-17 CA CA002392576A patent/CA2392576A1/fr not_active Abandoned
- 2000-11-17 AU AU17700/01A patent/AU1770001A/en not_active Abandoned
- 2000-11-17 JP JP2001540072A patent/JP2003514897A/ja active Pending
- 2000-11-17 WO PCT/US2000/031520 patent/WO2001038309A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1235807A1 (fr) | 2002-09-04 |
JP2003514897A (ja) | 2003-04-22 |
WO2001038309A1 (fr) | 2001-05-31 |
AU1770001A (en) | 2001-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6545055B1 (en) | Inhibitors of factor Xa | |
CA2385592C (fr) | Benzamides et inhibiteurs correspondants du facteur xa | |
US6638980B1 (en) | Inhibitors of factor Xa | |
US6844367B1 (en) | Benzamides and related inhibitors of factor Xa | |
US20030114448A1 (en) | Inhibitors of factor Xa | |
US20030069250A1 (en) | Benzamide inhibitors of factor Xa | |
WO2002026712A2 (fr) | Amines quaternaires et inhibiteurs du facteur xa associes | |
CA2371904A1 (fr) | Inhibiteurs du facteur xa | |
CA2392576A1 (fr) | Inhibiteurs du facteur xa a base d'acides .beta.-amines, aspartiques et diaminopropioniques | |
WO2002079145A1 (fr) | Composes de benzamide, inhibiteurs ddu factor xa | |
US20040082786A1 (en) | Piperazine based inhibitors of factor xa | |
US20040077690A1 (en) | Quaternary amidino based inhibitors of factor xa | |
WO2002026718A2 (fr) | Inhibiteurs du facteur xa à base de pyrimidine-4-one bicyclique | |
WO2002006280A2 (fr) | Inhibiteurs du facteur xa | |
US20040072860A1 (en) | Piperazin-2-one amides as inhibitors of factor xa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |